Are Home Genome Tests a Step Away from Eugenics?
By Annalee Newitz,
AlterNet
| 11. 29. 2007
A company called 23andme.com launched last week and got wads of media attention for being the first user-friendly Web site devoted to home genomics tests and analysis. For just $1,000, the company will take a swab of your cheek, sequence your genome, and tell you a bunch of things about how you fit into the Family of Humanity. They'll also allegedly give you nifty details about yourself, such as whether you have athletic abilities or a propensity for disease.
And 23andme is just the beginning. Another company called DeCode offers a similar service called DeCodeMe, and more are sure to follow. People are desperate to understand themselves, and so they turn to genetics as if it were a self-help manual instead of a still poorly understood science. While there are many theories about how genetic expression works on our personalities and health, there are few solid facts. Some tests, such as those for various kinds of developmental disabilities, have provable results. But many genetic tests, like those 23andme claim can reveal "athletic ability" are the biotech version of snake oil...
Related Articles
By Darren Incorvaia, Fierce Biotech | 07.16.2026
Jennifer Doudna, Ph.D., the Nobel Laureate best known for co-inventing the CRISPR system that has become the foundation for gene editing, is dipping her toes into a new, buzzy field: AI-powered protein design.
In a new paper, published today...
By Risa Cromer, The Conversation | 07.17.2026
By Emily Packard Dawson and Lainie Friedman Ross , The Hastings Center for Bioethics | 07.16.2026
Major news outlets recently reported – based on a bioRxiv preprint – that scientists had edited genes in human embryos with “startling precision.” The scientists’ decision to release this work ahead of peer review, coupled with the extensive media coverage...
Media coverage of recent developments in embryo gene editing might seem to suggest that gene-edited babies are close to becoming a reality. As tech billionaires eager to profit off of techno-eugenics invest in “designer baby” technologies, attempts to normalize heritable genome editing – which remains unsafe and raises significant ethical and societal concerns – are especially dangerous. It’s worth taking a closer look at these developments and what they mean, in a way that pushes back on narratives normalizing the...